Though prior reports have shown that statins can have anti-glioma effects and have linked them to components of the Transforming Growth Factor-beta (TGF-β) pathway [3–10], the statins have not previously been shown to potently inhibit TGF-β as their primary anti-cancer mechanism. The gene discussed is TGFB1; the disease is central nervous system cancer.